Evidence map›Paper›PMID 34716787›Full record

ArticleApplied microbiology and biotechnology2021

Efficacy of focal applications of a mycoinsecticide to control Aedes aegypti in Central Brazil.

Juan M Martinez, Juscelino Rodrigues, Ricardo N Marreto, Gabriel M Mascarin, Éverton K K Fernandes, Richard A Humber, Christian Luz

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Systematic Review of the Ovitrap Surveillance ofTropical medicine and infectious disease · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Juan M MartinezLaboratório de Patologia de Invertebrados (LPI), Instituto de Patologia Tropical e Saúde Pública (IPTSP), Universidade Federal de Goiás (UFG), Avenida Esperança s/n, Campus Samambaia, GO, 74690-900, Goiânia, Brazil.
Juscelino RodriguesLaboratório de Patologia de Invertebrados (LPI), Instituto de Patologia Tropical e Saúde Pública (IPTSP), Universidade Federal de Goiás (UFG), Avenida Esperança s/n, Campus Samambaia, GO, 74690-900, Goiânia, Brazil.
Ricardo N MarretoLaboratório de Nanosistemas e Dispositivos de Liberação de Fármacos (NanoSYS), Faculdade de Farmácia, UFG, Goiânia, GO, Brazil.
Gabriel M MascarinEmbrapa Meio Ambiente, Jaguariuna, SP, Brazil.
Éverton K K FernandesLaboratório de Patologia de Invertebrados (LPI), Instituto de Patologia Tropical e Saúde Pública (IPTSP), Universidade Federal de Goiás (UFG), Avenida Esperança s/n, Campus Samambaia, GO, 74690-900, Goiânia, Brazil.
Richard A HumberUS Department of Agriculture, Agricultural Research Service, Ithaca, NY, USA.
Christian LuzLaboratório de Patologia de Invertebrados (LPI), Instituto de Patologia Tropical e Saúde Pública (IPTSP), Universidade Federal de Goiás (UFG), Avenida Esperança s/n, Campus Samambaia, GO, 74690-900, Goiânia, Brazil. wchrisluz@hotmail.com.ORCID http://orcid.org/0000-0002-5231-0735
Universidade Federal de Goiás · BRAgricultural Research Service · USSecretaria do Meio Ambiente · BR

Funding

conselho nacional de desenvolvimento científico e tecnológico Decit/SCTIE/MS (440506/2016)conselho nacional de desenvolvimento científico e tecnológico PQ 306319/2018-7conselho nacional de desenvolvimento científico e tecnológico PQ 311672/2016-7secretário de ciência, tecnologia e ensino superior, governo do estado de parana Decit/SCTIE/MS (440506/2016)
6 · The paper itself

Abstract

Entomopathogenic fungi can achieve important innovative outcomes for integrated mosquito control especially of Aedes aegypti, the key vector of arboviruses to humans in the tropics and subtropics. This study sought to design and to develop a simple dissemination device to attract and to infect gravid A. aegypti adults with a granular formulation of the ascomycete Metarhizium humberi IP 46, and to validate this device in the laboratory as well as in semi-field and field conditions. Hydrogel (polyacrylamide potassium polyacrylate) was confirmed to be a suitable substitute for water used in the device that attracted gravid females under field conditions. Females laid eggs on black polyethylene terephthalate carpet fixed in the device that also proved to be a suitable substrate for a granular formulation of fungal microsclerotia and/or conidia. The plastic device (29.5 cm high) was divided into a lower closed compartment with a water reservoir and an upper, laterally open but covered compartment with continuously hydrated gel and the fungal formulation attached to the carpet. The uppermost compartment permitted free circulation of mosquito adults. The device attracted both male and female A. aegypti. The fungal formulations of IP 46 propagules tested in the device were effective against adults in laboratory, semi-field, and field settings. Findings in the laboratory, semi-field, and especially in field conditions strengthen the value and utility of this innovative device for focal applications of a mycoinsecticide against this important mosquito vector.Key points• Low-cost and simple disseminating device for focal control of Aedes aegypti.• Granulized Metarhizium humberi IP 46 and hydrogel yield extended control.• Findings in field tests strengthen benefit of the device for focal application.

Indexed as

AedesMetarhiziumAnimalsBrazilFemaleHumansMaleMosquito VectorsBiological controlDissemination deviceField testFormulationMetarhiziumMosquito

Identifiers

PMID34716787
OpenAlexW3209593235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.